| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$351.25 |
800 |
$280,996 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$350.01 |
2,000 |
$700,014 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$344.49 |
5,839 |
$2,011,453 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$347.81 |
2,700 |
$939,094 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$WULFTERAWULF INC. |
Bucella Michael C.Director |
Buy |
$14.79 |
6,085 |
$89,967 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$343.56 |
2,240 |
$769,583 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$342.18 |
1,956 |
$669,305 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$341.41 |
1,813 |
$618,970 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$340.25 |
2,549 |
$867,293 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$NTRANatera, Inc. |
Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director |
Sell |
$339.24 |
1,481 |
$502,407 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$CHYMChime Financial, Inc. |
Feuille JamesDirector |
Sell |
$33.95 |
954 |
$32,388 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$LARKLANDMARK BANCORP INC |
LEWIS JIMDirector |
Sell |
$32.92 |
400 |
$13,168 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$BOCBOSTON OMAHA Corp |
Keating Brendan JosephDirector |
Sell |
$13.56 |
100,994 |
$1,369,782 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$AFLAFLAC INC |
Japan Post Holdings Co., Ltd.10% owner |
Sell |
$117.55 |
9,581 |
$1,126,247 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$CHYMChime Financial, Inc. |
Feuille JamesDirector |
Sell |
$33.20 |
94,446 |
$3,135,607 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$LSCCLATTICE SEMICONDUCTOR CORP |
Desale PravinSVP, R&D |
Sell |
$105.97 |
2,379 |
$252,113 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$PINSPINTEREST, INC. |
Silbermann BenjaminDirector, 10% owner |
Sell |
$19.22 |
46,875 |
$900,923 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$PVLAPALVELLA THERAPEUTICS, INC. |
JENKINS GEORGE MDirector |
Sell |
$149.38 |
954 |
$142,507 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$PHVSPharvaris N.V. |
Glassman RobertDirector |
Sell |
$38.27 |
8,667 |
$331,716 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$PMAPMA Graphene Technology Group Inc. |
Lam Chi MingDirector |
Sell |
$1.30 |
99,114 |
$128,868 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$XYZBlock, Inc. |
Eisen Anthony MathewDirector |
Sell |
$79.31 |
6,000 |
$475,860 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$AMBQAmbiq Micro, Inc. |
Esaka FumihideChief Executive Officer, Director |
Sell |
$61.00 |
100 |
$6,100 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$AMBQAmbiq Micro, Inc. |
Esaka FumihideChief Executive Officer, Director |
Sell |
$60.55 |
9,615 |
$582,171 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$AMBQAmbiq Micro, Inc. |
Esaka FumihideChief Executive Officer, Director |
Sell |
$59.56 |
3,785 |
$225,444 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$PVLAPALVELLA THERAPEUTICS, INC. |
JENKINS GEORGE MDirector |
Sell |
$151.33 |
560 |
$84,743 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$PVLAPALVELLA THERAPEUTICS, INC. |
JENKINS GEORGE MDirector |
Sell |
$150.40 |
263 |
$39,556 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$MRVLMarvell Technology, Inc. |
MURPHY MATTHEW JChairman of the Board and CEO, Director |
Sell |
$223.39 |
7,500 |
$1,675,425 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$TELATELA Bio, Inc. |
Capper Joseph HDirector |
Buy |
$1.06 |
50,000 |
$52,940 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$TENXTENAX THERAPEUTICS, INC. |
Giordano Christopher ThomasCEO, Director |
Buy |
$1.82 |
4,850 |
$8,837 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-15 |
$SNEXStoneX Group Inc. |
Maurer Mark LowryChief Risk Officer |
Sell |
$67.02 |
50,528 |
$3,386,629 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$RCGRENN Fund, Inc. |
HORIZON KINETICS ASSET MANAGEMENT LLC10% owner |
Buy |
$3.05 |
756 |
$2,306 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$LSCCLATTICE SEMICONDUCTOR CORP |
Desale PravinSVP, R&D |
Sell |
$106.77 |
200 |
$21,354 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$LSCCLATTICE SEMICONDUCTOR CORP |
Desale PravinSVP, R&D |
Sell |
$105.00 |
1,700 |
$178,503 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$MAXMediaAlpha, Inc. |
Nonko EugeneDirector |
Sell |
$11.49 |
7,273 |
$83,538 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$MAXMediaAlpha, Inc. |
Nonko EugeneDirector |
Sell |
$11.48 |
1,940 |
$22,272 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-16 |
$MAXMediaAlpha, Inc. |
Cramer KeithChief Revenue Officer |
Sell |
$11.49 |
13,000 |
$149,422 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$AFLAFLAC INC |
Japan Post Holdings Co., Ltd.10% owner |
Sell |
$116.84 |
4,019 |
$469,580 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$ROIVRoivant Sciences Ltd. |
Epperly Melissa B,Director |
Sell |
$39.65 |
4,338 |
$172,002 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$ALPAlpha Compute Corp |
Villani FiorenzoSee Remarks, Director |
Buy |
$4.15 |
7,900 |
$32,811 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Dube Eric MCHIEF EXECUTIVE OFFICER, Director |
Sell |
$62.66 |
28,796 |
$1,804,222 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
REED ELIZABETH EChief Legal Officer and GC |
Sell |
$65.31 |
300 |
$19,593 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
REED ELIZABETH EChief Legal Officer and GC |
Sell |
$63.69 |
1,400 |
$89,166 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
REED ELIZABETH EChief Legal Officer and GC |
Sell |
$62.63 |
13,874 |
$868,965 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
REED ELIZABETH EChief Legal Officer and GC |
Sell |
$62.03 |
21,926 |
$1,359,971 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Inrig JulaEVP, Head of R&D & CMO |
Sell |
$65.31 |
400 |
$26,124 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Inrig JulaEVP, Head of R&D & CMO |
Sell |
$63.69 |
1,600 |
$101,896 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Inrig JulaEVP, Head of R&D & CMO |
Sell |
$62.62 |
17,284 |
$1,082,397 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Inrig JulaEVP, Head of R&D & CMO |
Sell |
$62.02 |
25,390 |
$1,574,604 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER |
Sell |
$65.31 |
1,431 |
$93,458 |
EDGAR Form 4 ↗ |
| 2026-09-15filed 2026-09-17 |
$TVTXTravere Therapeutics, Inc. |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER |
Sell |
$63.65 |
1,400 |
$89,113 |
EDGAR Form 4 ↗ |